VICTORIOUS seeks collaborations to further develop the Project

VICTORIOUS Project is focused on the development of a patented anticancer technology. The project has successfully completed validation in 27 human ex vivo tumor cultures, demonstrating selective and effective anticancer activity and supporting further advancement toward preclinical development. The technology addresses significant unmet medical needs and offers promising opportunities for future clinical translation.

The Project is actively seeking collaborations with investors, pharmaceutical and biotechnology companies, venture capital funds, contract research organizations, technology transfer offices, and strategic partners interested in supporting the next stages of development, including TRL scaling, preclinical studies, regulatory planning, licensing opportunities, and commercialization. Her goal is to accelerate the translation of innovative biomedical research into impactful healthcare solutions that improve patient outcomes and generate societal and economic value.